Schedule 13G ownership disclosure

APTEVO THERAPEUTICS INC

Common Stock, $0.001 par value · CUSIP: 03835L306

Event date: 2025-04-03

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • BIGGER CAPITAL FUND L P

    Shares: 200,000.00 · Class: 6.20%

  • Bigger Capital Fund GP, LLC

    Shares: 200,000.00 · Class: 6.20%

  • Bigger Michael

    Shares: 200,000.00 · Class: 6.20%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000921895-25-001026
Form type
SCHEDULE 13G
Filer
Aptevo Therapeutics Inc.
CIK
CIK 1671584
Filed
Apr 08, 2025
Reporting period
Apr 03, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub